• Data
    • Overview
    • Clinical notes
    • Images
    • Mother-child
    • Oncology
    • Regulatory grade
    • Truveta Language Model
    • Truveta Studio
  • Genomics
  • Solutions
    • Life science
    • Public health
    • Healthcare
  • Research
  • Resources
  • About
    • Blog
    • Members
    • Leadership
    • Events & webinars
    • Newsroom
    • Careers
Get started
Sign in
Raising the bar: Truveta’s approach to real-world data quality

Raising the bar: Truveta’s approach to real-world data quality

by Truveta staff | Jan 31, 2024 | Data

Clinical trials and registries have traditionally been the gold standard for high-quality healthcare data, offering complete longitudinal records across data domains in a clean, analysis-ready format. However, achieving this level of quality involves significant...
Trends in pediatric RSV immunizations and RSV-associated hospitalizations: October 2018 to December 2023

Trends in pediatric RSV immunizations and RSV-associated hospitalizations: October 2018 to December 2023

by Truveta staff | Jan 26, 2024 | Research

Truveta Research explored the rates of pediatric RSV immunizations and pediatric RSV-associated hospitalizations for children under the age of two. Of the 1,872,292 children under age two who were eligible to receive an RSV immunization, 3.7% of the eligible...
Real-time monitoring of respiratory virus-associated hospitalizations: Trends from October 2019 through December 2023

Real-time monitoring of respiratory virus-associated hospitalizations: Trends from October 2019 through December 2023

by Truveta staff | Jan 23, 2024 | Research

Overall, the rate of hospitalizations associated with respiratory viruses continues to increase (92.8% increase from November 2023 to the end of December 2023). The largest increases in hospitalizations over the past month were associated with influenza (251.7%...
Real-time monitoring of GLP-1 RA medications: Prescription trends from January 2018 through December 2023

Real-time monitoring of GLP-1 RA medications: Prescription trends from January 2018 through December 2023

by Truveta staff | Jan 23, 2024 | Research

Overall prescribing rates (GLP-1 RA prescriptions per total prescriptions) have remained stable in the last 3 months, with rates in December 2023 about the same as rates in November 2023 and October 2023. For the anti-diabetic medications (ADMs), the number of...
Truveta awarded real-world data contract by the CDC to study COVID, maternal health, and pediatric care

Truveta awarded real-world data contract by the CDC to study COVID, maternal health, and pediatric care

by Truveta staff | Jan 22, 2024 | News

Truveta, a growing collective of 30 health systems with a shared mission of Saving Lives with Data, was awarded a contract with the U.S. Centers for Disease Control and Prevention (CDC) for privacy-preserving record linkage of patient-level real-world healthcare data....
« Older Entries
Next Entries »

Share this


Recent posts

  • Evaluating recent trends in early measles vaccinations in Texas
  • Cancer innovation needs better data—not just better drugs
  • ISPOR 2025: Trends in the prescribing and dispensing of GLP-1 anti-obesity medications among adults with cardiovascular disease

Follow Truveta


Sign up for our newsletter

Ready to accelerate your research with representative, complete, and timely real-world data?

Get started

Truveta Data

Truveta Genome Project

Solutions

Research

Resources

Blog

Newsroom

Careers

Privacy notice

Contact us

© Truveta 2025

Interested in learning more?

Our website uses cookies to ensure you have the best experience.AcceptPrivacy notice